Clinical trials
Active, not recruiting Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
892 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 11 |
| 2011 | 13 |
| 2012 | 8 |
| 2013 | 23 |
| 2014 | 29 |
| 2015 | 43 |
| 2016 | 40 |
| 2017 | 47 |
| 2018 | 55 |
| 2019 | 80 |
| 2020 | 76 |
| 2021 | 97 |
| 2022 | 96 |
| 2023 | 86 |
| 2024 | 73 |
| 2025 | 52 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 892 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 45 |
| M.D. Anderson Cancer Center | 37 |
| AstraZeneca | 26 |
| Dana-Farber Cancer Institute | 26 |
| City of Hope Medical Center | 22 |
| National Cancer Institute (NCI) | 19 |
| Pfizer | 18 |
| Eli Lilly and Company | 15 |
| Fudan University | 11 |
| Massachusetts General Hospital | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 892 |
| Triple Negative Breast Neoplasms | 59 |
| Ovarian Neoplasms | 43 |
| Colorectal Neoplasms | 39 |
| Prostatic Neoplasms | 39 |
| Lung Neoplasms | 38 |
| Neoplasm Metastasis | 38 |
| Neoplasms | 38 |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Pancreatic Neoplasms | 23 |
Trials
Showing 51 to 75 of 892. Each trial links to its page on Pharma Observatory.
792 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.